Abiraterone

What is Abiraterone?

Abiraterone is an oral medication primarily used in the treatment of prostate cancer. It belongs to a class of drugs known as androgen biosynthesis inhibitors. Specifically, Abiraterone works by blocking the production of androgens (male hormones) throughout the body, including in the testes, adrenal glands, and the prostate tumor itself. These hormones are known to fuel the growth of prostate cancer cells. By significantly reducing androgen levels, Abiraterone helps to slow down or stop the progression of the disease. It is often prescribed as Abiraterone acetate, an ester form that is converted into the active Abiraterone in the body. It is available under various brand names, most notably Zytiga.

How Does it Work?

The core mechanism of action for Abiraterone involves its potent and selective inhibition of the enzyme cytochrome P450 17α-hydroxylase/C17,20-lyase (CYP17). This enzyme is a critical component in the androgen biosynthesis pathway, responsible for the production of androgens like testosterone and dihydrotestosterone (DHT). By acting as a CYP17 inhibitor, Abiraterone effectively prevents the synthesis of these hormones. Unlike traditional androgen deprivation therapy (ADT) which primarily targets testicular androgen production, Abiraterone also inhibits androgen production in the adrenal glands and within the tumor tissue itself. This comprehensive blockade of androgen synthesis is crucial because prostate cancer cells can adapt and continue to produce androgens locally, even after surgical or medical castration. By disrupting this pathway, Abiraterone deprives cancer cells of the necessary growth stimuli, leading to tumor regression or stabilization.

Medical Uses

Abiraterone is approved for the treatment of specific types of prostate cancer. Its primary indication is for men with metastatic castration-resistant prostate cancer (CRPC). This is a form of prostate cancer that continues to progress despite a patient having undergone androgen deprivation therapy, which aims to lower testosterone levels to castrate levels. Abiraterone is used in both chemotherapy-naïve patients (those who have not yet received chemotherapy) and those who have previously received docetaxel chemotherapy. It is typically administered in combination with a corticosteroid, such as prednisone or prednisolone, to manage and mitigate certain side effects, particularly mineralocorticoid excess, which can arise from the drug's mechanism of action. Clinical trials have demonstrated that Abiraterone significantly improves overall survival and progression-free survival in men with CRPC, making it a cornerstone of modern prostate cancer treatment strategies.

Dosage

The standard recommended oral dose of Abiraterone acetate is 1,000 mg (four 250 mg tablets) taken once daily. It is crucial for patients to take the medication exactly as prescribed by their healthcare provider. For the original formulation (Zytiga), it should be taken on an empty stomach, at least one hour before or two hours after food. Food can significantly increase the absorption of Abiraterone, leading to higher drug levels and potentially increased side effects. However, newer formulations (e.g., Yonsa) may have different dosing instructions regarding food, so patients must follow specific guidance for their prescribed product. Abiraterone is always administered in combination with a low dose of prednisone or prednisolone (e.g., 5 mg twice daily) to help reduce the incidence and severity of certain adverse events, particularly those related to mineralocorticoid excess, such as hypertension, hypokalemia, and fluid retention. Regular monitoring of blood pressure, serum potassium, and liver function is essential during treatment with Abiraterone.

Side Effects

Like all potent medications, Abiraterone side effects can occur, ranging from mild to severe. Common side effects often include fatigue, joint pain or swelling, hot flashes, diarrhea, and nausea. Due to its mechanism of affecting hormone balance, patients may experience symptoms related to mineralocorticoid excess, such as fluid retention (edema), high blood pressure (hypertension), and low potassium levels (hypokalemia). These are usually managed with concomitant corticosteroid administration and close monitoring. More serious, though less common, side effects include liver problems (hepatotoxicity), which can manifest as elevated liver enzymes, severe adrenal insufficiency, and cardiovascular issues like arrhythmia or heart failure. Patients should report any unusual symptoms, especially severe fatigue, yellowing of the skin or eyes, dark urine, severe abdominal pain, or swelling in the ankles or feet, to their doctor immediately. Regular blood tests are performed to monitor liver function, potassium levels, and other relevant parameters throughout treatment.

Drug Interactions

Abiraterone can interact with several other medications, potentially altering their effects or increasing the risk of adverse reactions. It is primarily metabolized by the liver enzymes CYP3A4 and SULT2A1, and it can inhibit CYP2D6 and CYP2C8. Therefore, caution is advised when Abiraterone is co-administered with drugs that are substrates of these enzymes. For example, co-administration with strong CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine) may decrease Abiraterone plasma concentrations, reducing its efficacy. Conversely, strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin) may increase Abiraterone levels, potentially leading to more side effects. Drugs metabolized by CYP2D6 (e.g., metoprolol, thioridazine, propafenone) may have increased exposure when taken with Abiraterone, requiring dose adjustments. Additionally, Abiraterone's effect on androgen levels might impact other hormone-sensitive medications. Patients must inform their healthcare provider about all prescription drugs, over-the-counter medications, herbal supplements, and vitamins they are taking to avoid potential interactions.

FAQ

Is Abiraterone a chemotherapy drug?

No, Abiraterone is not considered a traditional chemotherapy drug. It is a form of hormonal therapy, specifically an androgen biosynthesis inhibitor. Chemotherapy drugs directly kill rapidly dividing cells, including cancer cells, while Abiraterone works by blocking the production of male hormones (androgens) that fuel prostate cancer growth.

How long can I take Abiraterone?

Abiraterone is typically taken continuously until your prostate cancer progresses or until you experience unacceptable side effects. The duration of treatment varies greatly among individuals, depending on their response to the medication and their tolerance of its side effects. Your doctor will regularly assess your condition to determine the appropriate length of treatment.

What should I avoid while taking Abiraterone?

It's generally recommended to avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of Abiraterone and potentially increase its levels in the body. You should also avoid taking certain herbal supplements, such as St. John's wort, which can reduce Abiraterone's effectiveness. Always consult your doctor or pharmacist before taking any new medications or supplements.

Can Abiraterone cure prostate cancer?

Abiraterone is not a cure for prostate cancer, but it is a highly effective treatment that can significantly extend the lives of men with castration-resistant prostate cancer, improve their quality of life, and delay disease progression. It helps manage the disease by controlling cancer growth and reducing related symptoms.

Products containing Abiraterone are available through trusted online pharmacies. You can browse Abiraterone-based medications at ShipperVIP or Medicenter.

Summary

Abiraterone is a vital oral medication in the landscape of prostate cancer treatment, particularly for men with metastatic castration-resistant prostate cancer. By acting as a potent and selective CYP17 inhibitor, it effectively blocks the production of androgens in multiple sites, thereby depriving cancer cells of the hormones they need to grow. Its use, typically in combination with a corticosteroid like prednisone, has been shown to significantly improve overall survival and delay disease progression. While offering substantial benefits, patients must be aware of potential side effects, including those related to mineralocorticoid excess and liver function, and adhere strictly to prescribed dosages and administration guidelines. Close monitoring by healthcare professionals is essential to manage side effects and ensure optimal therapeutic outcomes. Understanding Abiraterone's mechanism, uses, and potential interactions empowers patients and caregivers in managing this challenging disease.